桃小食心虫成虫期高表达气味结合蛋白基因的克隆与表达谱分析

【目的】桃小食心虫Carposina sasakii是我国北方落叶果树的重要蛀果害虫,一旦幼虫蛀入果内,便会对果实的品质产生影响。成虫期是控制此害虫发生为害的关键时期。气味结合蛋白(odorant binding protein, OBP)作为昆虫嗅觉感受系统中与气味分子结合的重要气味运转蛋白,在成虫寄主植物定位及交配行为中具有重要作用。本研究对桃小食心虫气味结合蛋白基因进行克隆、鉴定和成虫组织表达分析,以期为OBPs在桃小食心虫嗅觉感受过程中的功能研究奠定基础。【方法】基于前期获得的桃小食心虫转录组测序数据,选择在其雌雄成虫触角中相对高表达的5个OBP基因(CsasOBP7, CsasOBP12, CsasOBP15, CsasOBP19和CsasOBP21)。采用RACE技术克隆出这5个OBP基因cDNA全长序列,进行生物信息学分析;通过qRT-PCR技术检测这5个OBP基因在桃小食心虫不同发育阶段(1和5日龄卵、初孵幼虫、老熟幼虫和蛹)以及在刚羽化、交配高峰期的和交配后6 h的雌雄成虫不同组织［触角、头(不含触角)、胸、腹、足和翅］中表达量。【结果】获得桃小食心虫5个OBP基因CsasOBP7, CsasOBP12, CsasOBP15, CsasOBP19和CsasOBP21的全长cDNA序列(GenBank登录号: MZ476786-MZ476790)。其中CsasOBP19为一段C端不完整的Minus-C OBP,其余均属于完整的Classical OBPs,且均含有信号肽。系统发育分析表明,在桃小食心虫5个CsasOBPs中, CsasOBP7和CsasOBP19的亲缘关系最近。qRT-PCR结果表明,CsasOBP7和CsasOBP19均在桃小食心虫蛹期高表达,而CsasOBP12, CsasOBP15和CsasOBP21均在卵期高表达。从桃小食心虫成虫刚羽化、交配高峰直至交配后6 h,5个CsasOBP基因表达量总体呈下降趋势。在成虫刚羽化时,这5个CsasOBP基因在各组织中均有表达,且主要在雄虫组织中高表达;在成虫交配高峰期,这5个CsasOBP基因在雄虫触角中高表达,特别是CsasOBP7和CsasOBP15只在雄虫触角中特异性表达;在成虫交配后6 h,每个CsasOBP基因只特异性地高表达于1或2个组织中。【结论】桃小食心虫的这5个CsasOBP基因在成虫交配高峰期雄虫触角中高表达,意味着这些CsasOBP基因可能在雄虫寻找雌虫过程中发挥着重要作用。     

一种猪模型的体外肺灌注系统的建立

目的:体外肺灌注技术(Ex vivo lung perfusion, EVLP)对于肺移植的实施意义重大,但成本昂贵。本文采用国产经济材料建立猪模型的EVLP系统,以探索保证系统性能的同时降低移植费用。方法:我们首先依据国产材料配置肺灌注液,并组装管道、连接仪器以建立EVLP系统;之后通过外科手段获得3头家猪的肺脏,并灌注肺灌注液,低温保存6小时;最后我们将肺脏连接到EVLP系统,通过血气分析和肺功能检查来评估肺脏随时间变化的状况。结果:离体并在低温保存6小时的猪肺脏,通过我们建立的相对经济的EVLP系统,可以在2小时内维持良好的氧合功能和肺生理指标:肺动脉压、气道峰压、平台压力、肺动脉氧气分压和二氧化碳分压和左心房的氧气分压和二氧化碳分压都保持稳定,同时肺脏具有正常的颜色和弹性,没有明显水肿和功能损害。结论:我们建立的EVLP系统可以有效地维护离体猪肺的生理功能,且降低了成本,从而为肺移植体外肺灌注技术的优化应用提供了研究基础。     

Trichostatin A alters the expression of cell cycle controlling genes and microRNAs in donor cells and subsequently improves the yield and quality of cloned bovine embryos in vitro

Trichostatin A (TSA), a histone deacetylase inhibitor, has been used to improve nuclear reprogramming in somatic cell nuclear transfer embryos. However, the molecular mechanism of TSA for the improvement of the pre- and postimplantation embryonic development is unknown. In the present study, we investigated mechanism of cell cycle arrest caused by TSA and also determined embryo quality and gene expression in cloned bovine embryos produced from TSA-treated donor cells compared with embryos produced by in vitro fertilization or parthenogenetic activation. We observed that, 50 nM TSA-treated cells were synchronized at G0/G1 stage with concomitant decrease in the proportion of these cells in the S stage of the cell cycle, which was also supported by significant changes in cell morphology and decreased proliferation (P < 0.05). Measurement of relative expression using real-time polymerase chain reaction of a some cell cycle–related genes and microRNAs in treated donor cells showed decreased expression of HDAC1, DNMT1, P53, CYC E1, and CDK4 and increased expression of DNMT3a, CDKN1A, CDK2, CDK3, miR-15a, miR-16, and miR-34a (P < 0.05). No change in the relative expression of miR-449a was noticed. Trichostatin A treatment of donor cells significantly improved both cleavage and blastocyst rate (P < 0.05) compared with the control embryos, also apoptotic index in treated cloned blastocysts was significantly decreased compared with the nontreated blastocysts (P < 0.05) and was at the level of IVF counterpart. Relative expression of HDAC1 and DNMT3a was significantly lower in treated cloned and parthenogenetic embryos than that of nontreated and IVF counterpart, whereas in case of P53, expression level between treated and IVF embryos was similar, which was significantly lower than nontreated cloned and parthenogenetic embryos. In conclusion, our data suggested that TSA improves yield and quality of cloned bovine embryos by modulating the expression of G0/G1 cell cycle stage–related microRNA in donor cells, which support that TSA might be great cell cycle synchronizer apart from potent epigenetic modulator in cloning research in future.     

Analysis of emergence stage facilitates the evaluation of chickpea (Cicer arietinum L.) genotypes for salinity tolerance imparted by mycorrhizal colonization

Salinity is an ever-increasing constraint limiting crop production in arid and semi-arid regions. Arbuscular mycorrhiza (AM) helps host plant to cope with detrimental effects of salinity. Experiments were aimed to examine the hypothesis that emergence is a better stage to determine salt tolerance of chickpea genotypes than germination and genotypic variability in their tolerance ability at emergence and subsequent vegetative growth is the manifestation of differential benefits imparted by mycorrhiza. Investigations were carried out at germination and emergence stage of genotypes (PBG 5, GPF 2, PBG 1, BG 1053, L 550) at 0, 40, 60, 80 mM NaCl. Significant genotypic variations in salt tolerance were observed at emergence rather than germination because of greater inhibitory effects on seedling emergence. Percent mycorrhizal colonization (MC) and its resulting impact on respiration rate (RR) and salt tolerance index (STI) at emergence indicated that PBG 5, with lowest RR, highest STI and mycorrhiza benefit percentage was the most tolerant whereas, L 550 the most sensitive genotype. Genotypic variability recorded at 30 days was consistent with that at emergence stage. Superior salt tolerance of PBG 5 than L 550 could be attributed to higher correlation between MC and physio-biochemical traits (RWC, chlorophyll a/b, proline accumulation, antioxidant activities). The study supported the hypothesis that both emergence stage and mycorrhizal effectiveness are important determinants of salt tolerance in chickpea genotypes. Evaluation of genotypes for relative adaptation to salinity should include estimation of their differential salt tolerance at different growth stages and symbiotic effectiveness of AM .     

QSAR-Based Models for Designing Quinazoline/Imidazothiazoles/Pyrazolopyrimidines Based Inhibitors against Wild and Mutant EGFR

Overexpression of EGFR is responsible for causing a number of cancers, including lung cancer as it activates various downstream signaling pathways. Thus, it is important to control EGFR function in order to treat the cancer patients. It is well established that inhibiting ATP binding within the EGFR kinase domain regulates its function. The existing quinazoline derivative based drugs used for treating lung cancer that inhibits the wild type of EGFR. In this study, we have made a systematic attempt to develop QSAR models for designing quinazoline derivatives that could inhibit wild EGFR and imidazothiazoles/pyrazolopyrimidines derivatives against mutant EGFR. In this study, three types of prediction methods have been developed to design inhibitors against EGFR (wild, mutant and both). First, we developed models for predicting inhibitors against wild type EGFR by training and testing on dataset containing 128 quinazoline based inhibitors. This dataset was divided into two subsets called wild_train and wild_valid containing 103 and 25 inhibitors respectively. The models were trained and tested on wild_train dataset while performance was evaluated on the wild_valid called validation dataset. We achieved a maximum correlation between predicted and experimentally determined inhibition (IC₅₀) of 0.90 on validation dataset. Secondly, we developed models for predicting inhibitors against mutant EGFR (L858R) on mutant_train, and mutant_valid dataset and achieved a maximum correlation between 0.834 to 0.850 on these datasets. Finally, an integrated hybrid model has been developed on a dataset containing wild and mutant inhibitors and got maximum correlation between 0.761 to 0.850 on different datasets. In order to promote open source drug discovery, we developed a webserver for designing inhibitors against wild and mutant EGFR along with providing standalone (http://osddlinux.osdd.net/) and Galaxy (http://osddlinux.osdd.net:8001) version of software. We hope our webserver (http://crdd.osdd.net/oscadd/ntegfr/) will play a vital role in designing new anticancer drugs.     

Notch-1 Mediated Cardiac Protection following Embryonic and Induced Pluripotent Stem Cell Transplantation in Doxorubicin-Induced Heart Failure

Doxorubicin (DOX), an effective chemotherapeutic drug used in the treatment of various cancers, is limited in its clinical applications due to cardiotoxicity. Recent studies suggest that transplanted adult stem cells inhibit DOX-induced cardiotoxicity. However, the effects of transplanted embryonic stem (ES) and induced pluripotent stem (iPS) cells are completely unknown in DOX-induced left ventricular dysfunction following myocardial infarction (MI). In brief, C57BL/6 mice were divided into five groups: Sham, DOX-MI, DOX-MI+cell culture (CC) media, DOX-MI+ES cells, and DOX-MI+iPS cells. Mice were injected with cumulative dose of 12 mg/kg of DOX and 2 weeks later, MI was induced by coronary artery ligation. Following ligation, 5×10⁴ ES or iPS cells were delivered into the peri-infarct region. At day 14 post-MI, echocardiography was performed, mice were sacrificed, and hearts were harvested for further analyses. Our data reveal apoptosis was significantly inhibited in ES and iPS cell transplanted hearts compared with respective controls (DOX-MI+ES: 0.48±0.06% and DOX-MI+iPS: 0.33±0.05% vs. DOX-MI: 1.04±0.07% and DOX-MI+CC: 0.96±0.21%; p<0.05). Furthermore, a significant increase in levels of Notch-1 (p<0.05), Hes1 (p<0.05), and pAkt (p<0.05) were observed whereas a decrease in the levels of PTEN (p<0.05), a negative regulator of Akt, was evident following stem cell transplantation. Moreover, hearts transplanted with stem cells demonstrated decreased vascular and interstitial fibrosis (p<0.05) as well as MMP-9 expression (p<0.01) compared with controls. Additionally, heart function was significantly improved (p<0.05) in both cell-transplanted groups. In conclusion, our data show that transplantation of ES and iPS cells blunt DOX-induced adverse cardiac remodeling, which is associated with improved cardiac function, and these effects are mediated by the Notch pathway.     

Quantitative Ex-Vivo Micro-Computed Tomographic Imaging of Blood Vessels and Necrotic Regions within Tumors

Techniques for visualizing and quantifying the microvasculature of tumors are essential not only for studying angiogenic processes but also for monitoring the effects of anti-angiogenic treatments. Given the relatively limited information that can be gleaned from conventional 2-D histological analyses, there has been considerable interest in methods that enable the 3-D assessment of the vasculature. To this end, we employed a polymerizing intravascular contrast medium (Microfil) and micro-computed tomography (micro-CT) in combination with a maximal spheres direct 3-D analysis method to visualize and quantify ex-vivo vessel structural features, and to define regions of hypoperfusion within tumors that would be indicative of necrosis. Employing these techniques we quantified the effects of a vascular disrupting agent on the tumor vasculature. The methods described herein for quantifying whole tumor vascularity represent a significant advance in the 3-D study of tumor angiogenesis and evaluation of novel therapeutics, and will also find potential application in other fields where quantification of blood vessel structure and necrosis are important outcome parameters.     

Cell therapy in the heart

Cell therapy is emerging as a new strategy to circumvent the adverse effects of heart disease. Many experimental and clinical studies investigating the transplantation of cells into the injured myocardium have yielded promising results. Moreover, data from these reports show that transplanted stem cells can engraft within the myocardium, differentiate into major cardiac cell types, and improve cardiac function. However, results from clinical trials show conflicting results. These trials demonstrate significant improvements in cardiac function for up to 6 months. However, these improved functions were diminished when examined at 18 months. In this review, we will discuss the current literature available on cell transplantation, covering studies ranging from animal models to clinical trials.